Now showing items 1-5 of 5
Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study
Context Randomised controlled trials (RCTs) can answer questions of efficacy, but rarely generate a complete safety profile. Long term pharmacovigilance studies complement RCTs. Objectives Level I evidence supports short ...
Adverse events in hospice and palliative care: a pilot study to determine feasibility of collection and baseline rates
(Mary Ann Liebert, Inc., 2011-01-19)
Background: Continuous quality improvement is fundamental in all health care, including hospice and palliative care. Identifying and systematically reducing symptomatic adverse events is limited in hospice and palliative ...
A collateral benefit of research in palliative care
(Mary Ann Liebert, Inc., 2011-09-12)
A collateral benefit of being in a research-active clinical unit is that there is evidence that better care is delivered. The most dramatic data to date demonstrate that in cardiology, research- active cardiology departments ...
Palliative care clinical trials: how nurses are contributing to ethical, integrated and evidence based care of palliative care patients participating in clinical trials
(Max Allen Healthcare, 2011)
The aim of this paper is to describe the emerging role of the palliative care clinical trials nurse in an era of evidence based practice and increasing clinical trial activity in palliative care settings across Australia. ...
Progressing an evidence-base beyond case series
(Mary Ann Liebert, Inc., 2011-12-06)
High-quality randomized trials in hospice and palliative care are achievable to provide quality evidence to guide our practice especially if several sites work together to conduct the trial. Palliative medicine is a specialty ...